Severity
Moderate
FDA Drug recall · Reported January 17, 2018
Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.
Sca Pharmaceuticals recalled Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syringe, Total Vol… - a moderate-severity action.
Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syringe, Total Vol… was recalled by Sca Pharmaceuticals in January 17, 2018. Reason: Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.. Check the official notice for the remedy. Verify recall #D-0156-2018 with the FDA Drug before acting.
The recall
Sca Pharmaceuticals issued this moderate-severity FDA Drug recall-Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date..
Sourced from official FDA Drug enforcement records. Verify recall #D-0156-2018 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0156-2018) was formally reported on January 17, 2018, with the manufacturer initiating the action on December 7, 2017. It is classified under Moderate severity (Class II), with a current status of Terminated. Sca Pharmaceuticals is listed as the recalling firm, operating out of Little Rock, AR. Federal records list the affected scope as 1248 syringes.
The documented reason for this recall is: Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date. Distribution data in the federal record shows the product reached: U.S.A. Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
1248 syringes
Related Recalls
6
0 from same agency
Ephedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syringe, Total Volume 10 mL, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205, NDC 70004-0600-12
Labeling: Incorrect or Missing Lot and/or Exp Date - product label was missing lot number and beyond use date.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | D-0156-2018 |
| Date reported | January 17, 2018 |
| Date initiated | December 7, 2017 |
| Recalling firm | Sca Pharmaceuticals |
| Firm location | Little Rock, AR |
| Affected scope | 1248 syringes |
| Distribution | U.S.A. Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported January 17, 2018. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.